Page 3 - Celltrans Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Implantable "drug factories" that kill advanced-stage ovarian and colorectal cancer in mice in six day could be ready for human clinical trials this fall.

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS issued its proposed FY 2022 payment updates for inpatient psychiatric and rehabilitation facilities, hospice, and skilled nursing facilities. Read more about the updates and other news below. I. Regulations, Notices & Guidance On April 5, 2021, the Food and Drug Administration...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, President Biden unveiled a $2.25 trillion infrastructure and tax proposal called the American Jobs Plan. Read more about the plan and other news below. I. Regulations, Notices & Guidance On March 30, 2021, the Department of Health and Human Services (HHS) issued its Semiannual Reg...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, CMS announced additional funding to support the 2021 Special Enrollment Period (SEP) for Marketplace health coverage. Read more about the announcement and other news below. I. Regulations, Notices & Guidance On March 4, 2021, the Food and Drug Agency (FDA) issued guidance entitled...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news. Week in Review Highlight of the Week: This week, HHS announced new actions to expand COVID-19 testing capacity across the country. Read more about the announcement and other news below. I. Regulations, Notices & Guidance On February 18, 2021, the Food and Drug Administration (FDA) issued a notice entitled, Guidance Documents Re...